Abstract

Purpose After radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC), pre- and postinterventional contrast-enhanced CT (CECT) images are usually qualitatively interpreted to determine technical success, by eyeballing. The objective of this study was to evaluate the feasibility of quantitative assessment, using a nonrigid CT-CT coregistration algorithm. Materials and Methods 25 patients treated with RFA for HCC between 2009 and 2014 were retrospectively included. Semiautomated coregistration of pre- and posttreatment CECT was performed independently by two radiologists. In scans with a reliable registration, the tumor and ablation area were delineated to identify the side and size of narrowest RFA margin. In addition, qualitative assessment was performed independently by two other radiologists to determine technical success and the anatomical side and size of narrowest margin. Interobserver agreement rates were determined for both methods, and the outcomes were compared with occurrence of local tumor progression (LTP). Results CT-CT coregistration was technically feasible in 18/25 patients with almost perfect interobserver agreement for quantitative analysis (κ = 0.88). The interobserver agreement for qualitative RFA margin analysis was κ = 0.64. Using quantitative assessment, negative ablative margins were found in 12/18 patients, with LTP occurring in 8 of these patients. In the remaining 6 patients, quantitative analysis demonstrated complete tumor ablation and no LTP occurred. Conclusion Feasibility of quantitative RFA margin assessment using nonrigid coregistration of pre- and postablation CT is limited, but appears to be a valuable tool in predicting LTP in HCC patients (p=0.013).

Highlights

  • Radiofrequency ablation (RFA) has been recognized as first line treatment for very early-stage hepatocellular carcinoma (HCC) and is used as treatment for unresectable early-stage HCC, according to the Barcelona Clinic for Liver Cancer (BCLC) staging system [1, 2]

  • A consensus reevaluation of one case led to agreement on technical success that the radiologists initially disagreed on

  • A disadvantage of minimally invasive HCC treatments is that no pathological confirmation of treatment success can be obtained. e chance on treatment success is generally thought to increase when aiming at safety margins of 5 or 10 mm, to overcome potential heat-transduction variations caused by factors such as heat sink, tumor heterogeneity, and liver parenchyma fibrosis or cirrhosis

Read more

Summary

Introduction

Radiofrequency ablation (RFA) has been recognized as first line treatment for very early-stage hepatocellular carcinoma (HCC) (lesion diameter

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call